1. Home
  2. PRTA

as 04-10-2025 10:41am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

;SMA (50)$13.84EMA (200)$17.65O: $11.24 H: $11.50 L: $10.36 C: $10.48 −0.76 (−6.76%)Elder Ray −0.67, −1.81
Founded: 2012 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN 2
Market Cap: 809.8M IPO Year: N/A
Target Price: $54.57 AVG Volume (30 days): 533.5K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.27 EPS Growth: N/A
52 Week Low/High: $9.30 - $25.42 Next Earning Date: 05-07-2025
Revenue: $135,157,000 Revenue Growth: 47.92%
Revenue Growth (this year): -62.18% Revenue Growth (next year): 131.73%

PRTA Daily Stock ML Predictions

SELLHOLDBUYas of 2 days ago

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use